BCL2 and chronic kidney disease: We hypothesized that doxorubicin-induced cytotoxicity in feline kidney cells and the kidney tissue of cats with chronic kidney disease (CKD) would lead to increased levels of TGF-β1 and MAPK and decreased levels of Bcl-2.